Man Group PLC Lannett CO Inc Transaction History

Man Group PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$6.36 - $10.05 $173,589 - $274,304	-27,294 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$8.49 - $12.81 $271,680 - $409,920	-32,000 Reduced 53.97%	27,294 $241,000
Q3 2019 Nov 14, 2019	SELL	$5.58 - $14.47 $922,965 - $2.39 Million	-165,406 Reduced 73.61%	59,294 $664,000
Q2 2019 Aug 14, 2019	SELL	$5.22 - $9.08 $21,924 - $38,136	-4,200 Reduced 1.83%	224,700 $1.36 Million
Q1 2019 May 15, 2019	BUY	$5.35 - $9.82 $975,839 - $1.79 Million	182,400 Added 392.26%	228,900 $1.8 Million
Q4 2018 Feb 14, 2019	BUY	$3.43 - $6.19 $159,495 - $287,835	46,500 New	46,500 $231,000
Q3 2018 Nov 14, 2018	SELL	$4.75 - $14.5 $53,817 - $164,285	-11,330 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.3 - $17.45 $150,689 - $197,708	11,330 New	11,330 $154,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.